A collection of reagents or other associated materials intended to be used to detect or monitor the V617F mutation in the Janus kinase 2 (JAK2) gene in a clinical specimen, using a nucleic acid technique (NAT). This mutation is associated with haematological abnormalities that may include essential thrombocythemia, polycythemia vera, primary myelofibrosis or leukaemia.